Skip to main content

COVID19

  • COVID-19

COVAX

  • COVAX

Country Hub

  • Country portal | COVAX platform

Secondary nav

  • The Break COVID Now Summit
  • Ethics Hotline

Donate

  • Donate
  • EN
  • FR
Home

Main navigation

Menu
  • Our Alliance
    Our Alliance
    • About
    • Strategy
      • Phase 5 (2021-2025)
        • The equity goal
        • The healthy markets goal
        • The sustainability goal
        • The vaccine goal
      • Phase 4 (2016-2020)
        • The market shaping goal
        • The sustainability goal
        • The systems goal
        • The vaccine goal
      • Phase 3 (2011-2015)
        • The financing goal
        • The health systems goal
        • The market shaping goal
        • The vaccine goal
      • Phase 2 (2006-2010)
      • Phase 1 (2000-2005)
      • Risk management
      • Vaccine investment strategy
      • Gender and immunisation
    • Operating model
      • Gavi's partnership model
        • The Bill & Melinda Gates Foundation
        • UNICEF
        • WHO
        • The World Bank Group
        • Civil society organisations
        • Developing country governments
        • Developing country pharmaceutical industry
        • Industrialised country governments
        • Industralised country pharmaceutical industry
        • Research and technical institutes
      • Gavi's business model
      • Gavi Secretariat
      • Transparency and IATI
    • Governance
      • Gavi Board
        • Board Committees
        • Board composition
        • Board members
        • Board and Committee minutes
        • Calendar
      • Governance and legal structures
      • Corporate Policies
      • Audit and Investigations
    • Market Shaping
      • The Vaccine Innovation Prioritisation Strategy
      • Supply and procurement roadmaps
      • Product information for vaccines and cold chain equipment
      • Vaccine demand forecasting
    • Global Health & Development
      • Decade of vaccine collaboration
      • International Health Partnership for UHC 2030
      • Millennium Development Goals
      • Sustainable Development Goals
      • UN Global Strategy for Women's, Children's and Adolescents' Health
    • Work with us
      • Culture
      • Vacancies
      • Internship programme
      • RFPs and Consulting Opportunities

    @SaveTheChildren / Hanna Adcock

    #VaccinesWork
     

    Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

    FOCUS AREAS Zero-Dose Child Gavi@20 Progress report Partners Our Board

    CAREERS Current vacancies Internship programme RFPs and consulting

    Contact us Phishing and fraud

  • Programmes & Impact
    Programmes & Impact
    • How our support works
      • Gavi Support Guidelines
      • Independent Review Committee
      • Joint appraisals
      • Grant performance frameworks
      • Country portal and COVAX collaboration platform
    • Types of support
      • Vaccine support
        • Human papillomavirus
        • Inactivated polio vaccine
        • Japanese encephalitis
        • Measles and measles-rubella
        • Meningitis A
        • Oral cholera
        • Pentavalent
        • Pneumococcal
        • Rotavirus
        • Typhoid
        • Yellow fever
      • Health system and immunisation strengthening
        • Immunisation supply chain
        • Data
        • Leadership, management and coordination
        • Demand promotion
      • Partners' engagement framework
        • Targeted country assistance
        • Strategic focus areas
        • Foundational support
      • Making immunisation sustainable
        • Eligibility
        • Transitioning out of Gavi support
        • Co-financing
      • Civil society organisation
    • Country Hub
      • Africa
        • Angola
        • Benin
        • Burkina Faso
        • Burundi
        • Cameroon
        • Central African Republic (the)
        • Chad
        • Comoros
        • Congo
        • Congo, DR
        • Côte d’Ivoire
        • Eritrea
        • Ethiopia
        • Gambia
        • Ghana
        • Guinea
        • Guinea-Bissau
        • Kenya
        • Lesotho
        • Liberia
        • Madagascar
        • Malawi
        • Mali
        • Mauritania
        • Mozambique
        • Niger
        • Nigeria
        • Rwanda
        • Sao Tome and Principe
        • Senegal
        • Sierra Leone
        • South Sudan
        • Tanzania, UR
        • Togo
        • Uganda
        • Zambia
        • Zimbabwe
      • Americas
        • Cuba
        • Haiti
        • Honduras
        • Nicaragua
        • Bolivia
        • Guyana
      • Eastern Mediterranean
        • Afghanistan
        • Djibouti
        • Pakistan
        • Somalia
        • Sudan
        • Yemen
      • Europe
        • Albania
        • Armenia
        • Azerbaijan
        • Bosnia & Herzegovina
        • Georgia
        • Kyrgyzstan
        • Moldova
        • Tajikistan
        • Turkmenistan
        • Ukraine
        • Uzbekistan
      • Southeast Asia
        • Bangladesh
        • Bhutan
        • India
        • Indonesia
        • Korea, DPR
        • Myanmar
        • Nepal
        • Sri Lanka
        • Timor Leste
      • Western Pacific
        • Cambodia
        • China
        • Kiribati
        • Lao PDR
        • Mongolia
        • Papua New Guinea
        • Solomon islands
        • Vietnam
    • Our impact
      • Measuring our performance
        • 2011 - 2015 indicators
        • 2016 - 2020 indicators
      • Countries approved for support
      • Disbursements and Commitments
      • Evaluation studies
      • Facts and figures
      • Progress reports
    • Programmatic Policies
      • Co-financing policy
      • Eligibility and transitioning
      • Fragility, emergencies and refugees policy
      • Gender policy
      • Health system and immunisation strengthening support framework
      • Prioritisation mechanism
      • Risk policy
      • Self-procurement policy
      • Transparency and accountability
      • Vaccine donation policy

    SUPPORTED COUNTRIESSupported countriesGavi supported a total of 73 countries in 2018

    Explore our Country Hub

    FOR COUNTRIES

    Apply for support

    Gavi 5.0 Ceilings by country and support type

     

    OUR RESULTS

    Evaluation studies

    Facts and figures

    Progress reports

  • Investing in Gavi
    Investing in Gavi
    • Resource mobilisation process
      • The Gavi COVAX AMC 2022 Investment Opportunity
      • Gavi COVAX AMC Summit 2021
      • Gavi COVAX AMC Investment Opportunity 2021 Launch Event
      • Global Vaccine Summit 2020
      • Gavi's Investment Opportunity launch meeting, 30 August 2019
      • Gavi Mid-Term Review, Abu Dhabi high level conference, 10-11 December 2018
      • Previous events
        • Gavi pledging conference January 2015
        • Gavi replenishment launch meeting May 2014
        • Gavi Mid-Term Review meeting October 2013
        • Gavi pledging conference June 2011
        • Call for Action and Resources October 2010
        • Financing Country Demand March 2010
    • Funding
      • Overview 2000-2037
      • Current period 2021-2025
      • Donor profiles
        • Airtel Nigeria
        • Al Ansari Exchange
        • Alight Solutions
        • Alwaleed Philanthropies
        • Analog Devices Foundation
        • Asia Philanthropy Circle (APC)
        • Audacious Alliance
        • Australia
        • Austria
        • Belgium
        • The Bill & Melinda Gates Foundation
        • Blackberry
        • Brazil
        • Burkina Faso
        • Cameroon
        • Canada
        • Centene Charitable Foundation
        • China
        • Cisco
        • Coca-Cola Foundation
        • Colombia
        • Croatia
        • Denmark
        • ELMA Vaccines and Immunization Foundation
        • Epiroc AB
        • Estonia
        • European Commission
        • Finland
        • France
        • Germany
        • Girl Effect
        • Google
        • Greece
        • HH Sheikh Mohammed bin Zayed Al Nahyan
        • Iceland
        • India
        • International Federation of Pharmaceutical Wholesalers
        • Ireland
        • Italy
        • Japan
        • Kingdom of Bhutan
        • Kingdom of Saudi Arabia
        • KS Relief
        • "la Caixa" Banking Foundation
        • Laerdal
        • Liechtenstein
        • Luxembourg
        • Malta
        • Mastercard
        • Mauritius
        • McHugh O'Donovan Foundation
        • Mexico
        • The Netherlands
        • New Zealand
        • Niger
        • Norway
        • Orange
        • Other private donors
        • Pager Duty
        • Philippines
        • Poland
        • Portugal
        • Pratt & Whitney
        • Principality of Monaco
        • Proctor & Gamble
        • Reed Hastings and Patty Quillin
        • Republic of Korea
        • Rockefeller Foundation
        • Russell Reynolds Associates
        • Russian Federation
        • Salesforce
        • Shell International
        • Singapore
        • South Africa
        • Spain
        • Spotify
        • Stanley Black & Decker
        • State of Qatar
        • State of Kuwait
        • Sultanate of Oman
        • Sweden
        • Switzerland
        • Thistledown Foundation
        • TikTok
        • Toyota Tsusho
        • Twilio
        • Uganda
        • UBS Optimus Foundation
        • Unilever
        • United Kingdom
        • United States of America
        • UPS
        • Vaccine Forward Initiative
        • Vietnam
        • The Visa Foundation
        • Wise
        • Workday Foundation
    • Partnering with business
    • Innovative financing
      • IFFIm
      • Pneumococcal AMC
        • About the pneumococcal AMC
        • How it works
        • Manufacturers
        • How countries can apply
        • Timeline
        • Independent Assessment Committee
        • AMC legal agreements
      • Gavi Matching Fund
      • Loan buydown
    • INFUSE
      • INFUSE community
      • Call for innovations

    The Break COVID Now Summit 8 April 2022 Gavi COVAX AMC Investment Opportunity

    KEY AREAS

    Donor profiles

    Matching Fund

    Pneumococcal AMC

  • VaccinesWork
    VaccinesWork
    • About VaccinesWork
    • The science behind COVID-19
    • Emerging threats
    • Tales from the past
    • News from the lab
    • Stories from the community

    FEATURED STORY

    Health workers march against polio
     

    Read more

  • News & Resources
    News & Resources
    • Media room
      • News releases
      • Media contacts
      • Leadership biographies
    • Audio-visual
      • Videos
      • Galleries
      • Infographics
      • Presentations
    • Publications
    • Document library
      • COVID-19 situation reports
      • Evaluations
      • IRC reports
      • Financial reports

    KEY PUBLICATION

    Gavi innovation catalogue

    PROGRESS REPORT

    Download the 2020 Gavi progress report

  • The Break COVID Now Summit

  • EN
  • FR
  • Home
  • VaccinesWork
  • The Gavi COVAX AMC Explained
Gavi/2020/Maya Hautefeuille
Back to

The Gavi COVAX AMC Explained

Gavi’s CEO explains how the COVAX Advance Market Commitment mechanism will make COVID-19 vaccines available to lower-income countries.

By Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance

Back to

The Gavi COVAX AMC Explained

Gavi’s CEO explains how the COVAX Advance Market Commitment mechanism will make COVID-19 vaccines available to lower-income countries.

By Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance

COVAXVideosExplained
Home

Footer

  • Our Alliance
  • Programmes & impact
  • Investing in Gavi
  • VaccinesWork
  • News & resources

Country Hub

  • Country portal | COVAX platform

Donate

  • Donate

Footer nav

  • Careers
  • Contact
  • Ethics hotline
  • IFFIm
  • Privacy Policy
  • Terms of use
  • Phishing and fraud

© Gavi 2022

  • Gavi Facebook
  • Gavi Twitter
  • Gavi LinkedIn

Our achievements are thanks to the support and expertise of our founding partners